Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic target

Journal:

Nature Communications

Published:

2026-03-23

DOI:

10.1038/s41467-026-70817-1

Affiliations:

8

Authors:

18

Go to article

Institutions	Authors	Share
University Medical Center Freiburg, Germany	10.500000 10.500000	0.58
University of Freiburg (Uni Freiburg), Germany	2.166667	0.12
Charles River Laboratories Germany GmbH, Germany	2.000000	0.11
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	2.000000	0.11
DKTK Partner Site Freiburg, Germany	1.333333	0.07

Interested in Oncology and Carcinogenesis?